chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; Dose 1: Moderna/ Dose 2: Moderna/ Dose 3: Moderna/ Dose 4: Moderna/ Dose 5: Pfizer; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 12:00 as dose 5 (booster), single (Lot number: 6H9694) at the age of 61 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 19Feb2021 at 12:00 as dose 1, single (Lot number: 011M20A), in right arm, on 19Mar2021 at 12:00 as dose 2, single (Lot number: 029A21A), in right arm, on 29Oct2021 at 12:00 as dose 3 (booster), single (Lot number: 076C21A), in right arm and on 19Apr2022 at 12:00 as dose 4 (booster), single (Lot number: 001M21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 19Apr2022 at 12:00, outcome "unknown", described as "Dose 1: Moderna/ Dose 2: Moderna/ Dose 3: Moderna/ Dose 4: Moderna/ Dose 5: Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 05Jul2023 to 09Jul2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300252481 Same reporter/patient, different drug, different AE.;
Information was received from physicians office. Post vaccine pt experienced soreness at the injection site with warmth, redness, and swelling.
Patient has rash on both arms and chest.  She says it just itches a little bit.  She has tried taking an antihistamine but rash has not cleared up.  She said she will give it a few more days to see if it clears up and will let us know.
Starting on 1/5/2021, I had a rash from my ankle up to my calf on both legs. I still have the rash on both legs, but it's not as pronounced as it was in the beginning. I was given a topical steroid, which I was to use for 2 weeks and no longer. The steroid cream helped relieve the itch. The rash still occasionally itches, but not as much as in the beginning. If it itches and you scratch it, it feels kind of like there are needles or bits of glass.
REPORTS THAT HE BROKE OUT WITH RED BLISTERS ON THE LEFT DELTOID AREA 48 HOURS AFTER SHOT GIVEN.  SAW PHYSICIAN FRIDAY 4/24 AND DR SAID IT WAS REACTION TO SHINGLES SHOT.  ALSO HIS WIFE BROKE OUT WITH SEVERE SHINGLES ON FRIDAY 4/24/09 AND SHE DID NOT GET VACCINE AS SHE IS UNDER AGE OF 60.  CLIENT HAS COMPLETL Y RECOVERED HIMSELF.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 02-SEP-2015, the patient was vaccinated with expired vaccine PNEUMOVAX 23 (unknown strength, route and dose) lot # K004483 with an expiry date of 16-AUG-2015. Concomitant medications were not reported. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
WHEN I WAS GETTING OUT OF BED I WAS VERY DIZZY AND UNSTABLE.  I SAT ON THE BED FOR ABOUT 10 MINS AND WAS ABLE TO WALK AROUND, BUT FELT LIGHT HEADED. I CHECKED MY BLOOD PRESSURE AND BLOOD SUGAR  AND THEY WERE FINE. I HAVE NO PAIN. I GOT UP THIS MORNING FEB. 6 AT 6 AM. I SAT ON BED FOR A FEW MINUTES BEFORE I STOOD UP AND I FELT UNSTABLE FOR A FEW MINUTES, BUT DOG OKAY.
Sore arm at injection site.  Know this is normal, but on 3rd day it got considerably worse and this is now a week later, and arm is much better, but for 2-3 days it was painful.   Scheduled to back for 2nd injection on Feb. 13.  Is this going to be a problem?  Was told by oncologist 2 1/2 years ago not to use right arm for anything.   Do not want to miss 2nd injection.  OK to have injection again in the left arm?
1640 Red palms, flushed, arms itch hx sensitive skin feels throat full. denies, dysphagia or dyspnea.  Benadryl 25mg po. 1645 Vital signs 160/100,97%,76. 1655 D/C amb. without problems.
Patient's mom stated that Vivienne's face was swelling up  and some rashes.  No other symptoms
Back Pain And Stiffness; Back Pain And Stiffness; Lethargy; General Aches And Joint Pain; General Aches And Joint Pain; Left Arm Soreness; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 01Mar2021 07:45 (at the age of 59-year-old) (Lot Number: ENG198) as dose 1, single for COVID-19 immunization. Medical history included high blood glucose increased, overweight, and COVID-19 (prior to vaccination). The patient did not have any known allergies. Concomitant medications included red rice yeast; cetirizine hydrochloride (ZYRTEC) and zinc, all taken for an unspecified indication, start and stop dates were not reported. The patient experienced left arm soreness, back pain and stiffness, lethargy, general aches and joint pain on 02Mar2021 06:00. The patient did not receive treatment for the events. The outcome of events was recovered. Since vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
I had eye strain all day April 8, 2021 - the day after I received my first dose of the Pfizer COVID-19 vaccine.  My vision wasn't blurry, but my eyes definitely had to work harder to focus and by the end of the day were sore and tired.  I'm filing this report on April 9th and the eye strain seems to have diminished considerably.  It is almost 5pm and I'm noticing now that my eyes are a bit tired and very slightly sore.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with a dose of ZOSTAVAX, subcutaneous in the back of the arm or triceps area of the arm for prophylaxis. On unknown dates, the patients experienced drug administered at inappropriate site and no adverse event. The outcome of drug administered at inappropriate site and no adverse event was unknown. The reporter considered drug administered at inappropriate site and no adverse event to be not related to ZOSTAVAX.
Exactly one week post vaccination, woke up to peri injection site erythema, slightly raised with irregular border. Site measured 4cm x 12 cm x 2mm. This was accompanied by a strong metallic taste in mouth that was similar to experience at time of original injection.
Per patient, she began experiencing a rash around 30 minutes after getting the vaccine. The rash was located around her chest and face. The rash was red, there was no burning sensation or itching associated with it. Later the same night after getting the vaccine she began to experience bone pain in her legs, shakes, and chills. She also started to run a fever and noticed it took a while to catch her breath. She still is running a fever and notices shortness of breath today (2/16/2022).
Within five minutes of the vaccine my face broke out with a rash and was warm to the touch.  Doctor took my blood pressure and it was fine, recommended Benadryl when I got home.
The day after flu vaccine was administered, patient's mother noticed "huge red knot 4-5 inches in diameter". BENADRYL and ibuprofen given 10/19. Arm stayed swollen for 7-10 days after injection, site "turned purpley, like a bruise".
Steven Johnson's Syndrome within a few days of 12 mo vaccines, VARICELLA, Hep A, PREVNAR. Currently being treated with PREDNISOLONE and ROCEPHIN.
On 11/15/2000 the patient had a sore arm. On 11/17/2000 a bump appeared on the injection site. The physician reported that on 11/18/2000, the patient had "actual pox x 3 at the site". The patient reported that on 11/21/2000, that she had several pox around the injection site. The physician reported the patient recovered from the sore arm and the pox at the injection site. No further information is expected.
Pt had a ight spasm neck and woke up in the middle of the night. She was very nauseous throughout the following day of the shot.
36yo male presents to clinic with right upper arm pain, swelling and redness which developed 24hrs after he was given an anthrax booster. Pt has received prior with no reaction. 6cmx10cm indurated area which is firm and nonfluctuant with no drainage or discharge. Erythema with edema and warmth. No significant streaking. Area marked. Differential dx: Injection site reaction versus cellulitis. Likely an injection site reaction but will cover pt for cellulitis given holiday. Septra DS for 10 days with warm compresses and Tylenol for pain. Pt instructed to return tomorrow at 0730 if area of erythema has increased. Gave ER precautions. Pt's questions answered and expressed understanding.
Chills, fever, feeling unwell, fatigue Took 2 Tylenol
Started feeling nauseous soon after having breakfast after office visit. Did not vomit, but had to lie down all afternoon, only sipping small amounts of water. I felt certain that if I had not begun to rest, I would have lost my breakfast of an open beef souvlaki with scrambled eggs, coffee and ice water. Had large loose bowel movement around 8:30 PM. Took two capsules of OTC loperamide hydrochloride afterwards. Continued resting, consumed about two cups of homemade beef stew after 11:30 PM. Had another loose bowel movement about 12:45 PM. Went to bed and slept several hours, dreaming about being in a rowboat with actress Kristen Stewart and inventing a spray to stick foam blocks together after two failed attempts. The following day I still felt weak and mildly feverish, but no longer nauseous. Rested all day again. Did not check temperature, but perspired more than usual while resting. Had another bowel movement about 10 AM and at 4 PM, but no longer felt the need for additional medication. This is being written about 5 PM.
Information has been received from an 81 year old female consumer with diabetes and no drug reactions or allergies who on 29-OCT-2007 was vaccinated with a single dose of ZOSTAVAX (Merck) (Lot # not reported). Concomitant therapy included insulin. About a week ago, on approximately 02-NOV-2010, the patient experienced shingles on her face. They were painful, scabby and ugly. At the time of the report the patient had not recovered. Patient sought unspecified medical attention. No lab diagnostics studies were performed. Additional information has been requested.
skin redness localized to area where the vaccine was given. / size of a palm of the hand.; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that about 2-3 years ago the patient received Shingrix and he developed skin redness localized to the area where the vaccine was given (shoulder area). It was the size of a palm of the hand. The reporter did not consent to follow up. No further details were available since it had happened so long ago. No need to follow up with RPH since she stated she had no further details. This is 1 of the 4 link cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020187932:Same Reporter US-GLAXOSMITHKLINE-US2020187931:Same Reporter US-GLAXOSMITHKLINE-US2020187917:same reporter
After the second dose, she felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (After the second dose, she felt tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A or 025L20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced FATIGUE (After the second dose, she felt tired). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 24-Feb-2021 for Tiredness, at an unspecified dose and frequency. At the time of the report, FATIGUE (After the second dose, she felt tired) outcome was unknown.            No concomitant medications reported.   This case was linked to MOD-2021-432443 (Patient Link).   Reporter did not allow further contact
Tenderness, Erythema, induration, urticaria to vaccine administer site, right thigh. Low grade temp since vaccines. Vaccine administered 11/03/2005, Pt seen in ER 11/05/2005 7:10 PM.
Initially started as severe back pain, immediately the spot of my spine fusion.  Followed by 2 days of flu like symptoms including 100 degree temperatures, sore throat and muscle pains.
Minor flu like symptoms. Fever, drowsiness, headache and excessive flatulence.   All symptoms dissipated within a few hours some farts remained throughout the day.
IM given in left arm 3rd dose. (Booster). Moderna Covid-19 Vaccine Lot 045C21A given was removed from freezer on 10/6/201 @ 11:45 am. Given on 11/5/21, out of time range.  Patient contacted that evening. Moderan manufacturer called. Patients called the following Monday letting them know ow that Moderna was looking into this and would be getting back to us. Also let them know I would be following up with them once we heard back from them. Called patient today 11/17/21 and let him know that Moderan let us know the vaccine was viable, no additional booster vaccine is required.
pt recvd vax 14DEC92 & pt exp severe abdo cramping & nausea; No further details were provided;
After mandatory waiting time of 15 minutes I left the facility, during driving to home I started feeling some sort of dizziness and palpitations.  I completed night duty at work, had my last meal at 5 am , I went to bed at 8 am, wake up at 1 pm to go for vaccination, just had water but no food.  I turn back to facility and reported, they ask me to sit for some more time, I took water  and was feeling better.
Information has been received from a pharmacist referring to a female patient of unknown age. The patient's concurrent conditions and medical history were not reported. On an unknown date in 2014, the patient vaccinated with a first dose of ZOSTAVAX (lot #, expiration date, dose and route were unknown). Then on 24-SEP-2015, the patient was inadvertently administered a second dose of ZOSTAVAX (lot#, expiration date, dose and route were unknown) (extra dose administered). The patient's concomitant medication was not reported.  On 25-SEP-2015 the patient developed a "half-dollar sized raised area of redness" at the injection site. The reported stated that the patient did not have an adverse effect after the first dose of ZOSTAVAX. No treatment was given to the patient. No lab diagnostics studies were performed. The patient had came to the pharmacy for medical attention. The outcome of th events was reported as recovering/resolving. Additional information is not expected as the reporter did not wish further contact.
Extreme fatigue; dizziness; This is a spontaneous report from a contactable consumer (patient reported herself). A 54-year-old non-pregnant female patient received second dose of BNT162B2 (COVID 19, Pfizer, Formulation: Solution for injection, Lot number: EN9581) via an unspecified route of administration on 05Feb2021 10:45 AM at single dose to her left arm for Covid-19 immunization. The patient's medical history included asthma. No known allergies were reported. Other medications in two weeks reported as yes. Historical vaccine included first dose of (COVID 19, Pfizer, Lot number: EL8982) on 15Jan2021 10:45 AM at single dose to her left arm for Covid-19 immunization. Facility type Vaccine: Workplace clinic. On 06Feb2021 10:00 AM, the patient experienced extreme fatigue and dizziness starting day after vaccine and still had four days later. Covid was not tested prior or post vaccination. The patient did not take any treatment in response to the events. Outcome of the events was not recovered.
Patient said on the anterior surface of her right arm from shoulder 1/2 way down to elbow was red and hot to touch. It is much better today she has been using BENADRYL and cold packs.
pt recvd vax 23MAR93; 11APR94 in pt's seventh month of pregnancy, pt had a misccarriage; addtl details are being requested;
Rash present to upper arms and chest starting on 3/16/08. Had smallpox vaccination on 6Mar08. Had missed take check that was scheduled for 3/15/08. MD evaluation noted Greater than 15 skin lesions noted on chest, upper arms and back. Single vesicle of 8cm induration noted on L deltoid d/t smallpox vaccination. Also diagnosed with sinusitis and Otitis Media to both ears.
Fever, SkinRash, NauseaVomiting, chills all similar with first dose Narrative:  Other Relevant History:
The symptoms I had fever, chills, sweats, nausea, and I pasted out about 6 to 8 hours after the vaccine. I have been diagnosed with Smoldering Myeloma.  I assume it has nothing to do with the vaccine.
FEVER DIARRHEA INJECTION-SITE REACTION (INFLAMED AND ITCHY) SHORTNESS OF BREATH RHINORRHEA UNCONTROLLABLE BURSTS OF SNEEZING, EXCEEDING 1 HOUR IN DURATION ASTHMA ATTACK WEAKNESS HEADACHE DIZZINESS NAUSEA MUSCLE PAIN
On Tuesday 4/22/08 I went in for a routine physical and PA suggested getting a tetanus booster vaccine. I received the vaccine by a med. assistant student around 2:15 pm and since then I have had excruciating continuous pain radiating from my upper arm to my elbow. I have been unable to complete personal care activities or work. On Tuesday 4/22/08 I called the practice and spoke to the triage nurse re: the excruciating pain (not soreness) and inability to move or lift my left arm. She advised me to alternate between Tylenol and Motrin; as well as apply a heat compress to the arm and call the service back in AM if worsens. I called back in the AM and the nurse advised me to come in to see PA again. Upon examination PA stated had inflamed muscles and I was having muscle spasms as a result of the vaccine. She stated that she had never seen this happen before. She prescribed Flexeril and Motrin Q8 hrs PRN pain. My condition (L arm) never got any better; in fact my (L) upper arm swelled even more and I began to have more pain (burning, sharp, shooting pain from my upper arm radiating to my elbow ). I called the practice back on Friday and Saturday and the triage nurse finally called me back and stated that PA will call in a prescription for LORTAB 1-2 tablets on Sunday. Well, I went to the office and stated that I feel they should report this reaction to the CDC since they stated that this never happens. The nurse just gave me the VAERS form and a MD note for work. I have missed (4) days of work and I still have pain and I still need assistance to perform regular activities. I am concerned that this batch of vaccine was tainted or the IM administration technique was performed incorrectly by the MA student. Please follow up with this.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Obese" (unspecified if ongoing), notes: Obese; "high blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a physician via a company representative referring to 3 patients of unknown gender, each of them was under age of 65 years old. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with PNEUMOVAX 23 (dose, route, lot # and expiration date not reported) at a pharmacy. Each patient was under the age of 65 years old and did not have an underlying medical condition. Additional information is not expected as no consent to contact the physician.
A nurse / gave Boostrix to a baby; This case was reported by a physician via sales rep and described the occurrence of inappropriate age at vaccine administration in a infant patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional details were provided as follows: Age at vaccination was not reported. The reporter reported that the nurse in the office gave Boostrix to the patient, which led to inappropriate age at vaccine administered. The reporter consented to follow up.
about 72 hours after flu shot, pt awoke with mild headache and body aches. Headache pain intensified to the 'worst headache ever' over the next 48 hours. Pt went to ER, CT and Spinal Tap normal. Treated with morphine and released. various treatments, hospitalization and tests (MRI, MRA and ep blood patch (x2)) no relief.  8 weeks later, still experiencing headaches from inflamed menins and w/associated low csf pressure. Medical records state weakness. msv
Information has been received from a medical assistant (RMA) concerning an unknown number of unspecified patients (unknown ages and genders). Pertinent medical history of the patients and their respective concurred conditions were not provided. It was reported that on 20-MAR-2016 or after, an unknown number of unspecified patients were vaccinated with improperly stored doses of M-M-R II lot # L011528, expiration date 03-APR-2017, (dosages, doses numbers and therapy routes were not reported). No adverse effects were reported at the time of the report. The excursion details were: Temperature: 9.8C- Time frame: 12 hours- There was no previous temperature excursion- It was call due to data logger. No product quality complaint (PQC) was involved. This is one of two reports from the same source (MARRS # WAES1608USA005970). Additional information has been requested.
This spontaneous report as received from a nurse refers to a 4 years old male patient. The patient was vaccinated with (Merck) VARIVAX (Lot# reported as 0694AE, dose/frequency, route and duration were unspecified) on an unknown date. Subsequently the patient experienced inflammation and swelling at the injection site on an unknown date. The location of where injection on the body was unspecified by the reporter. No treatment information was reported. The outcome was unknown. This is one of several reports received from the same source. Additional information is not expected.